Calliditas Therapeutics AB (CALT)

Form 15F-12B - Securities registration termination of foreign private issuers [Section 12(b)]

Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm

Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm PR Newswire STOCKHOLM, Sept. 16, 2024 STOCKHOLM, Sept. 16, 2024 /PRNewswire/...

Notice of extraordinary meeting of Calliditas Therapeutics AB (publ)

Notice of extraordinary meeting of Calliditas Therapeutics AB (publ) PR Newswire STOCKHOLM, Sept. 3, 2024 STOCKHOLM, Sept. 3, 2024 /PRNewswire/...

Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei

Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei PR Newswire STOCKHOLM, Sept. 3, 2024 STOCKHOLM...

Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei

Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei PR Newswire STOCKHOLM, Sept. 3, 2024 STOCKHOLM...

Calliditas Interim Report January to June 2024

Calliditas Interim Report January to June 2024 PR Newswire STOCKHOLM, Aug. 13, 2024 STOCKHOLM, Aug. 13, 2024 /PRNewswire/ -- Calliditas...

Calliditas Interim Report January to June 2024

Calliditas Interim Report January to June 2024 PR Newswire STOCKHOLM, Aug. 13, 2024 STOCKHOLM, Aug. 13, 2024 /PRNewswire/ -- Calliditas...

Invitation to the presentation of Calliditas´s interim report January - June 2024

Invitation to the presentation of Calliditas´s interim report January - June 2024 PR Newswire STOCKHOLM, Aug. 5, 2024 STOCKHOLM, Aug. 5, 2024...

Invitation to the presentation of Calliditas´s interim report January - June 2024

Invitation to the presentation of Calliditas´s interim report January - June 2024 PR Newswire STOCKHOLM, Aug. 5, 2024 STOCKHOLM, Aug. 5, 2024...

Calliditas Therapeutics to Attend 2024 Women in Nephrology (WIN) Leadership Conference

NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Calliditas Therapeutics AB (Nasdaq: CALT) (“Calliditas”) Chief...

Number of shares and votes in Calliditas Therapeutics

Number of shares and votes in Calliditas Therapeutics PR Newswire STOCKHOLM, July 31, 2024 STOCKHOLM, July 31, 2024 /PRNewswire/ -- During July...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA Nephropathy

Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA Nephropathy PR...

Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA Nephropathy

Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA Nephropathy PR...

Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis

Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis PR Newswire STOCKHOLM, July 26, 2024 STOCKHOLM, July...